Array ( [1617697613] => Array ( [wordfence_processAttackData] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => [args] => Array ( ) ) ) ) [1617698373] => Array ( [wp_privacy_delete_old_export_files] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1617698881] => Array ( [wpm_update_stats] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1617698971] => Array ( [wp_scheduled_auto_draft_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617700392] => Array ( [wordfence_hourly_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1617704111] => Array ( [delete_expired_transients] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617704152] => Array ( [wpseo-reindex-links] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617704814] => Array ( [wordfence_daily_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617715926] => Array ( [wp_update_themes] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_update_plugins] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1617716674] => Array ( [wp_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617717000] => Array ( [wordfence_start_scheduled_scan] => Array ( [9f22b2cbfcd99a92efa47e2e64f34692] => Array ( [schedule] => [args] => Array ( [0] => 1617717000 ) ) ) ) [1617719353] => Array ( [wp_version_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1617722273] => Array ( [wp_session_garbage_collection] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1617725224] => Array ( [akismet_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617728211] => Array ( [yoast_tracking] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617745261] => Array ( [wpseo_permalink_structure_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) [wpseo_home_url_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617745274] => Array ( [wpseo-reindex] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617776685] => Array ( [recovery_mode_clean_expired_keys] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617776690] => Array ( [wp_site_health_scheduled_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => weekly [args] => Array ( ) [interval] => 604800 ) ) ) [1617779312] => Array ( [ai1wm_storage_cleanup] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1617976200] => Array ( [wordfence_start_scheduled_scan] => Array ( [85f456078818ea524e18acf2267fc731] => Array ( [schedule] => [args] => Array ( [0] => 1617976200 ) ) ) ) )
Etiquetas: Bioequivalence, Biosimilar, Biosimilar medicines, Bruselas, CA, Centralised Procedure, CMD, Competent Authorities, EGA, EGA VISION 2015, European Generic Medicines Association, Harmonisation, Health, Making Medicines Affordable, Medicine applications, Medicines, MRAs, Mutual Recognition Agreements, Objective, October 2010, Octubre 2010, salud, Sanidad, Visión.
Etiquetas: 2005 - 2010, Atención especializada, Atención primaría, CA, Camas hospitalarias, Centros de Atención Especializada, Centros Especializados de Atención a las Urgencias, Financiación, Fuerteventura, Gobierno de Canarias, Gran Canaria, Inversión hasta 2010, Inversiones previstas, Lanzarote, Plan de Infraestructuras Sanitarias de Canarias, Provincia de Las Palmas, Recursos, Recursos de atención a la Salud Mental, salud, Sanidad, Sanidad Salud, SCS, Servicio Canario de Salud.
Etiquetas: AEMPS, Authorization and control of medicinal products, CA, Competent Authorities, EMEA, European Medicines Agency, Healthcare Products Agency, How to request online user access, Individual, Instructions, MAH, Marketing Authorisation Holder, Marketing Authorisation Holders, Ministerio de calidad y consumo, On electronic, Online data entry, Other requirements for electronic transmission, Parmaceutical Industry, Pharmaceutical companies, Pharmacoepidemioloy and Pharmacovigilance Division, Publications ICSR, Reports, Requirements for online data entry, Requirements for XML transmission, Rules establish, Safety, salud, Sanidad, Sending ICSRs from AEMPS to pharmaceutical companies, Spanish Medicines, Spanish Medicines and Healthcare Products Agency, technical requirements for electronic transmission of ICSRs, Transmission of suspected, Update, XML transmission.